Thank you for your interest in RoosterBio's webinar!
Extracellular Vesicles (EVs) are a growing segment of Regenerative Medicine and are particularly attractive as a therapeutic model utilizing a non-viable biologically active agent. In her presentation at ISEV 2020, Taby Ahsan will discuss considerations for manufacturing of EVs derived from mesenchymal stem/stromal cells, including the tissue source, the cell state, and process parameters. She will also discuss the importance of evaluating EV productivity in manufacturing processes, highlighting limitations and advantages of 2D and 3D bioreactor production.
Speaker: Dr. Taby Ahsan
Dr. Taby Ahsan has extensive experience in both basic and translation studies in the fields of tissue engineering and stem cells. For her training, she received her BSE at the University of Pennsylvania, her PhD at UCSD, and was a Postdoctoral Fellow at GA Tech. Shortly after her PhD, she worked at the tissue engineering company Advanced Tissue Sciences in La Jolla, CA. Starting in 2009, she was a faculty member in the Biomedical Engineering Department at Tulane University, leading an independent research laboratory focused on biomechanical regulation of both pluripotent and adult stem cells. Taby was also a Member and Chair of the Cell, Tissue, and Gene Therapy Advisory Council (CTGTAC) at the FDA. In 2017 Taby joined RoosterBio Inc. in her continued efforts to have a positive impact on public health.
About RoosterBio Inc.
RoosterBio, Inc. is a privately held cell manufacturing platform company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. Our products are high volume, affordable, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. We have simplified and standardized how stem cells are purchased, expanded, and used in development, leading to marked time and costs savings for customers. RoosterBio's innovative products are ushering in a new era of productivity and standardization to the field, accelerating the road to discovery in Regenerative Medicine.
For more information on RoosterBio, please visit http://www.roosterbio.com .